If you are interested in Hybridoma Core services, please contact Elizabeth Smith by phone at 734-763-9271 or by e-mail at firstname.lastname@example.org.
A project to develop a new monoclonal antibody generally requires a 30- to 45-minute meeting of the principal investigator and the involved laboratory staff with the Hybridoma Core director and a member of the Hybridoma Core staff.
Application forms for all other services are available by contacting Elizabeth Smith at 734-763-9271 or by e-mail at email@example.com.
Center Memberships (may qualify for discounted service rates)
RDCC members and potential members should contact Jan Stevens in the U-M Rheumatology Division at 734-936-9539 or by e-mail at firstname.lastname@example.org for membership information or an application for services. Project proposals from RDCC members must be pre-approved by the RDCC steering committee.
To apply for membership, please visit the Membership Web Page and select the "Apply for Membership/Obtain a Log-in" link near the bottom of the page. To qualify for a discount, proposals from MDRTC members will be reviewed to determine the relationship of the project to diabetes, its complications and related endocrine and metabolic disorders.